---
document_datetime: 2024-07-09 15:18:36
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/adcirca-epar-all-authorised-presentations_en.pdf
document_name: adcirca-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8486822
conversion_datetime: 2025-12-25 10:42:47.729908
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging        | Content (concentration)   | Pack size                                              |
|------------------|-------------------|------------|-----------------------|---------------------------|----------------------------|---------------------------|--------------------------------------------------------|
| EU/1/08/476/005  | Adcirca           | 20 mg      | Film-coated tablet    | Oral use                  | blister (alu/PVC/PE/PCTFE) |                           | 28 tablets                                             |
| EU/1/08/476/006  | Adcirca           | 20 mg      | Film-coated tablet    | Oral use                  | blister (alu/PVC/PE/PCTFE) |                           | 56 tablets                                             |
| EU/1/08/476/007  | Adcirca           | 2 mg/mL    | Oral suspension       | Oral use                  | bottle (PET)               | 220 mL                    | 1 bottle + 1 bottle adaptor + 2 oral syringes of 10 mL |